Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias.
Pérez de Isla L; SEC Working Group for the 2016 ESC Guidelines for the Management of Dyslipidemias:; Pérez de Isla L, Fernández PLS, Álvarez-Sala Walther L, Barrios Alonso V, Castro Conde A, Galve Basilio E, García Ortiz L, Mata López P; Expert Reviewers for the 2016 ESC Guidelines for the Management of Dyslipidemias:; Alegría Ezquerra E, Cordero Fort A, Cosin Sales J, Escobar Cervantes C, García-Moll Marimón X, José Gómez Doblas J, Marzal Martín D, Murga Eizagaechevarria N, de Pablo Zarzosa C, Miguel Rincón L, Sanchis Forés J; SEC Guidelines Committee:; Alberto San Román Calvar J, Alfonso Manterola F, Arribas Ynsaurriaga F, Evangelista Masip A, Ferreira González I, Jiménez Navarro M, Marín Ortuño F, Pérez de Isla L, Rodríguez Padial L, Luis Sánchez Fernández P, Sionis Green A, Vázquez García R.
Pérez de Isla L, et al. Among authors: de pablo zarzosa c.
Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):72-77. doi: 10.1016/j.rec.2017.01.001.
Rev Esp Cardiol (Engl Ed). 2017.
PMID: 28131410
English, Spanish.
No abstract available.